University of Maryland, Baltimore;Regeneron Pharmaceuticals, Inc.
发明人:
Alan Shuldiner,Nehal Gosalia,Cristopher Van Hout,Da-Wei Gong,James A. Perry
申请号：
US16823634
公开号：
US20200297752A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods of treating subjects having increased lipid levels, methods of identifying subjects having an increased risk of developing an increased lipid level, methods of detecting human Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) variant nucleic acid molecules and variant polypeptides, and SREBF1 variant nucleic acid molecules and variant polypeptides.
